CORAL GABLES, Fla., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced its financial results for the second quarter and six months ended June 30, 2011. For the three months ended June 30, 2011, the Company reported a net loss of $1,394,151, or $0.06 per basic and diluted share, compared to a net loss of $1,328,541, or $0.07 per basic and diluted share, for the same period in 2010. For the six months ended June 30, 2011, the Company reported a net loss of $2,911,287, or $0.14 per basic and diluted share, compared to a net loss of $2,373,584, or $0.13 per basic and diluted share, for the same period in 2010.
